Showing results (981-990 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|June 8, 2001
Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinaseH Hasegawa, M Shimada, Y Yonemitsu, et al.Cancer Gene Therapy|May 3, 2001
Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide productionM Baratin, M Ziol, R Romieu, et al.Cancer Gene Therapy|July 6, 2000
Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanismA L Rakhmilevich, K Janssen, Z Hao, et al.Cancer Gene Therapy|July 6, 2000
Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approachL M Anderson, S Krotz, S A Weitzman, et al.Cancer Gene Therapy|July 6, 2000
Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivoT S Kim, S W Chung, S H Kim, et al.Cancer Gene Therapy|July 6, 2000
Mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumorsW Walther, U Stein, I Fichtner, et al.Cancer Gene Therapy|July 6, 2000
Targeting of adenoviral vectors through a bispecific single-chain antibodyH J Haisma, J Grill, D T Curiel, et al.Cancer Gene Therapy|July 6, 2000
Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovirB D Howard, L Boenicke, B Schniewind, et al.Cancer Gene Therapy|July 6, 2000
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumorsT Todo, S D Rabkin, R L MartuzaCancer Gene Therapy|July 31, 2001
The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell linesJ Zhao, H Wang, L Wei, et al.Pageof 291